Arvinas (ARVN) EBIT (QoQ) (2017 - 2026)
Arvinas (ARVN) EBIT (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - |
| 2 | Nanobiotix | 1,941.00 Bn | 1,940.94 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.62 Bn | 468.83 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.20 Bn | 115.95 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - |
| 8 | Argenx Se | 56.57 Bn | 51.38 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn |
| 10 | Arvinas | 532.48 Mn | -82.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.48% |
| Dec 31, 2025 | -70.32% |
| Sep 30, 2025 | 38.74% |
| Jun 30, 2025 | -200.14% |
| Mar 31, 2025 | 222.68% |
| Dec 31, 2024 | 3.48% |
| Sep 30, 2024 | -24.33% |
| Jun 30, 2024 | 41.78% |
| Mar 31, 2024 | 49.61% |
| Dec 31, 2023 | -123.68% |
| Sep 30, 2023 | 0.94% |
| Jun 30, 2023 | 14.94% |
| Mar 31, 2023 | -16.01% |
| Dec 31, 2022 | -17.57% |
| Sep 30, 2022 | 2.28% |
| Jun 30, 2022 | -14.04% |
| Mar 31, 2022 | -21.47% |
| Dec 31, 2021 | -0.42% |
| Sep 30, 2021 | 8.86% |
| Jun 30, 2021 | -24.46% |